Podcast
Jason Cole – CEO & Chair of the Board, SalioGen
S2 Episode 2 of BioByteas by Windsor Bux welcomes Jason Cole – CEO & Chair of the Board, SalioGen
Jason Cole, a strategic biotech CEO, shares his career journey and insights on building successful biotech companies. He emphasizes the importance of collaboration, focus, and differentiation in the biotech industry. Jason also discusses the challenges of scaling a company, attracting investment, and maintaining strong relationships with stakeholders. He highlights the exciting potential of genetic medicine and the innovative work being done at SalioGen to develop therapies.
Takeaways
- Collaboration and delivering in your area of responsibility are key to career success in biotech.
- Raise your hand for opportunities and take on new responsibilities to advance your career.
- Foster a culture of collaboration by reinforcing the importance of teams and listening to stakeholders.
- Maintain a focus on differentiation and solving unique problems to attract investment and drive success in biotech.
- Engage with key stakeholders in a two-way conversation, approach with humility, and listen to their perspectives.
- Overcome setbacks and challenges by staying focused, being disciplined in resource allocation, and learning from failures.
- The potential of genetic medicine is exciting, and there are opportunities to develop innovative therapies for unmet medical needs.
You can also listen to this podcast on Spotify:
Welcome to BioBytes – Windsor Bux, where we bring you exclusive interviews with the movers and shakers of the biotech and pharmaceutical industry. Join us as we delve into the experiences and valuable insights of leading executives, exploring how they’re shaping the future and making a difference. Get ready for compelling conversations that will expand your knowledge and inspire your own journey in this exciting field!
- Shehnaaz Suliman, M.D, CEO at ReCode Therapeutics
- Sandy Milligan, MD JD, C-Suite Executive & Board Member
- Alex Oshmyansky, MD, PhD, CEO / Co-Founder
- Derek Adams, CEO & President
- Jason Cole – CEO & Chair of the Board, SalioGen
- David Donabedian, PhD – Executive Partner, Interim NewCo CEO, Longwood Fund
- Stephanie Oestreich, PhD, MPA Managing Director at Myeloma Investment Fund
- Ronan O’Hagan, Chief Executive Officer
- Alison Schecter, MD, CMO/CEO
- Joe Foster – Reebok, Founder